Kathleen Sereda Glaub - Net Worth and Insider Trading

Kathleen Sereda Glaub Net Worth

The estimated net worth of Kathleen Sereda Glaub is at least $203,944 dollars as of 2024-09-20. Kathleen Sereda Glaub is the Director of Codexis Inc and owns about 63,534 shares of Codexis Inc (CDXS) stock worth over $203,944. Details can be seen in Kathleen Sereda Glaub's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kathleen Sereda Glaub has not made any transactions after 2018-09-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Kathleen Sereda Glaub

To

Kathleen Sereda Glaub Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kathleen Sereda Glaub owns 3 companies in total, including Aligos Therapeutics Inc (ALGS) , Codexis Inc (CDXS) , and IO Biotech Inc (IOBT) .

Click here to see the complete history of Kathleen Sereda Glaub’s form 4 insider trades.

Insider Ownership Summary of Kathleen Sereda Glaub

Ticker Comapny Transaction Date Type of Owner
ALGS Aligos Therapeutics Inc 2020-10-15 director
CDXS Codexis Inc 2018-09-25 director
IOBT IO Biotech Inc 2021-11-04 director

Kathleen Sereda Glaub Latest Holdings Summary

Kathleen Sereda Glaub currently owns a total of 1 stock. Kathleen Sereda Glaub owns 63,534 shares of Codexis Inc (CDXS) as of September 25, 2018, with a value of $203,944.

Latest Holdings of Kathleen Sereda Glaub

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CDXS Codexis Inc 2018-09-25 63,534 3.21 203,944

Holding Weightings of Kathleen Sereda Glaub


Kathleen Sereda Glaub Form 4 Trading Tracker

According to the SEC Form 4 filings, Kathleen Sereda Glaub has made a total of 0 transactions in Codexis Inc (CDXS) over the past 5 years. The most-recent trade in Codexis Inc is the sale of 14,492 shares on September 25, 2018, which brought Kathleen Sereda Glaub around $272,884.

Insider Trading History of Kathleen Sereda Glaub

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kathleen Sereda Glaub Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Kathleen Sereda Glaub Ownership Network

Ownership Network List of Kathleen Sereda Glaub

No Data

Ownership Network Relation of Kathleen Sereda Glaub

Insider Network Chart

Kathleen Sereda Glaub Owned Company Details

What does Aligos Therapeutics Inc do?

Who are the key executives at Aligos Therapeutics Inc?

Kathleen Sereda Glaub is the director of Aligos Therapeutics Inc. Other key executives at Aligos Therapeutics Inc include 10 percent owner Roche Holding Ltd , 10 percent owner Roche Finance Ltd , and Chief Medical Officer Matthew W. Mcclure .

Aligos Therapeutics Inc (ALGS) Insider Trades Summary

Over the past 18 months, Kathleen Sereda Glaub made no insider transaction in Aligos Therapeutics Inc (ALGS). Other recent insider transactions involving Aligos Therapeutics Inc (ALGS) include a net purchase of 7,933,601 shares made by Carole Nuechterlein ,

In summary, during the past 3 months, insiders sold 0 shares of Aligos Therapeutics Inc (ALGS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aligos Therapeutics Inc (ALGS) were sold and 317,344 shares were bought by its insiders, resulting in a net purchase of 317,344 shares.

Aligos Therapeutics Inc (ALGS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aligos Therapeutics Inc Insider Transactions

No Available Data

Kathleen Sereda Glaub Mailing Address

Above is the net worth, insider trading, and ownership report for Kathleen Sereda Glaub. You might contact Kathleen Sereda Glaub via mailing address: C/o Codexis, Inc., 200 Penobscot Drive, Redwood City Ca 94063.

Discussions on Kathleen Sereda Glaub

No discussions yet.